Concepedia

Carol Cronenberger

CC

Statistics

Publications

14

Citations

580

H-Index

13

Active since

2007

Affiliations

Pfizer (United States)(Current)

Metroplex Clinical Research Center

Pfizer (United Kingdom)

Schlosspark-Klinik

The University of Texas Southwestern Medical Center

Carol Cronenberger is an author at Pfizer (United States) specializing in rheumatoid arthritis, rheumatoid arthritis pharmacotherapy, and rheumatology.

Publications per year

2007–2023

14

Publications

14

Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance

Wonkyung Byon, P Chan, MA Tortorici et al. · CPT Pharmacometrics & Systems Pharmacology · 2013 · 190 citations · Full text

, , +16

Ponezumab in mild‐to‐moderate Alzheimer's disease: Randomized phase II PET‐PIB study

Jaren W. Landen, Niels Andreasen, Carol Cronenberger et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2017 · 65 citations · Full text

, , +17

Multiple‐dose ponezumab for mild‐to‐moderate Alzheimer's disease: Safety and efficacy

Jaren W. Landen, Sharon Cohen, Clare B. Billing et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2017 · 62 citations · Full text

, , +17

A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis

Roy Fleischmann, Rieke Alten, Margarita Pileckytė et al. · Arthritis Research & Therapy · 2018 · 53 citations · Full text

, , +17

Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokers

Carol Cronenberger, Diane R. Mould, Hans‐Juergen Roethig et al. · British Journal of Clinical Pharmacology · 2007 · 29 citations · Full text

, , +16

1–5 of 14